Howard Capital Management (New York)’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $25.1M | Buy |
53,852
+214
| +0.4% | +$99.7K | 2.81% | 11 |
|
|
2020
Q3 | $23.7M | Buy |
53,638
+295
| +0.6% | +$130K | 2.99% | 10 |
|
|
2020
Q2 | $19.3M | Buy |
53,343
+22
| +0% | +$7.97K | 2.57% | 13 |
|
|
2020
Q1 | $15.1M | Sell |
53,321
-730
| -1% | -$207K | 2.58% | 12 |
|
|
2019
Q4 | $17.6M | Sell |
54,051
-100
| -0.2% | -$32.5K | 2.2% | 17 |
|
|
2019
Q3 | $15.8M | Sell |
54,151
-400
| -0.7% | -$117K | 2.25% | 18 |
|
|
2019
Q2 | $16M | Sell |
54,551
-139
| -0.3% | -$40.8K | 2.19% | 18 |
|
|
2019
Q1 | $15M | Buy |
54,690
+2,664
| +5% | +$729K | 2.11% | 16 |
|
|
2018
Q4 | $11.6M | Sell |
52,026
-85
| -0.2% | -$19K | 1.92% | 21 |
|
|
2018
Q3 | $12.7M | Buy |
52,111
+95
| +0.2% | +$23.2K | 1.7% | 26 |
|
|
2018
Q2 | $10.8M | Buy |
52,016
+341
| +0.7% | +$70.6K | 1.55% | 32 |
|
|
2018
Q1 | $10.7M | Buy |
51,675
+1,030
| +2% | +$213K | 1.55% | 33 |
|
|
2017
Q4 | $9.62M | Buy |
50,645
+30
| +0.1% | +$5.7K | 1.41% | 34 |
|
|
2017
Q3 | $9.58M | Buy |
50,615
+3,250
| +7% | +$615K | 1.48% | 33 |
|
|
2017
Q2 | $8.26M | Buy |
+47,365
| New | +$8.26M | 1.3% | 36 |
|